Investment and expertise
for promising, early-stage
Scottish technology and
life science companies.
We are a prominent
business angel syndicate,
which has been at the
forefront of early stage
investing in Scotland for
more than two decades.
We invest in companies
from the technology,
software and life sciences
sectors – three markets in
which Scotland produces
a wealth of talent.

Originally formed in 1992 and based in Edinburgh, Archangels is a prominent business angel syndicate which has been at the forefront of early stage investing in Scotland for more than a quarter of a century.

Latest News

  • Flexitricity and npower strike deal to deliver smart grid revenues to UK business

    Launch of SmartSTOR enables commercial energy users and small generators to earn revenue from spare energy capacity, increase asset reliability and reduce carbon emissions Source: New feed

  • Archangels celebrates £22m sale of pioneering Scots medical firm Mpathy Medical

    Archangels is delighted to announce the sale of Glasgow-based Mpathy Medical in a £22m deal with Danish health care product manufacturer, Coloplast. Archangels, Scotland’s leading business angel syndicate, was the principal investor in Mpathy Medical, the fastest growing company in women’s health and the developer of revolutionary mesh technology that allows surgeons to carry out […]

  • Anti spam firm Bloxx named fastest growing in Scotland

    Bloxx’s technology allows web pages or emails to be accurately classified and filtered in real-time. The Livingston-based web and email filtering company, Bloxx, has been named as the fastest growing in Scotland. The accountants Deloitte has placed Bloxx at 19th in a list of the top 50 fastest growing UK companies. The company has grown […]

  • KTH Royal Institute of Technology Opts for Arrayjet Inkjet Microarrayer Platform

    Roslin, UK – 11 October 2010: Arrayjet today announced that the KTH Royal Institute of Technology in Stockholm, has chosen its Marathon Inkjet Microarrayer for its Protein Array Technologies Group. Headed by Dr Peter Nilsson, the group, which will also serve as an Arrayjet reference site, is based in the Department of Proteomics and forms […]

  • New “Penicillin” for the 21st Century

    Today MGB Biopharma Limited, a late preclinical stage biopharmaceutical company, has commenced operations in Glasgow, UK to develop and commercialise a new class of antibacterial product: DNA Minor Groove Binders. Source: New feed

  • HAVmeter survives coldest winter since 1914!

    As construction of the M74 Completion is now well underway and the snow is finally melting, an unexpected item has emerged from the depths of an excavation. After enduring over two months of complete submersion in 2ft of frozen mud and icy water, a lone HAVmeter has been rescued. Source: New feed

Company portfolio

  • Archangel Investors Ltd
  • Archangel Investors Ltd
  • Archangel Investors Ltd

See our ‘Impact evaluation of activities report’ by the Hunter Centre for Entrepreneurship at The University of Strathclyde.